CBIZ (NYSE:CBZ) 株価情報

CBIZ

CBIZ Inc through its subsidiaries provides professional services advisors to middle-market businesses and organizations nationwide. Its business units have been aggregated into three practice groups: Financial Services, Benefits and Insurance Services, and National Practices. The company provides its services to various industries such as Banking & Financial Services, Commercial Real Estate, Construction, Health Care Manufacturing & Distribution NFP & Education, Private Client Services, Professional Services, Public Sector, and Technology & Life Sciences. It derives the majority of its revenues from the Financial Services segment and geographically from the United States.

CBIZ Inc

On March 10, a recent SEC filing unveiled that Benaree Pratt Wiley, Board Member at CBIZ (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBZ#NYSE">CBZ</a>) made an insider sell.
What Happened: According to a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0000944148/000112760225008931//Archives/edgar/data/944148/000112760225008931/0001127602-25-008931-index.htm">U.S. Securities and Exchange Commission</a> on Monday, Wiley sold 6,526 shares of CBIZ. The total transaction value is $468,214.
As of Tuesday morning, CBIZ shares are down by 0.0%, currently priced at $70.16.
<h3>Unveiling the Story Behind CBIZ</h3>
CBIZ Inc through its subsidiaries provides professional services advisors to middle-market businesses and organizations nationwide. Its business units have been aggregated into three practice groups: Financial Services, Benefits and Insurance Services, and National Practices. The company provides its services to various industries such as Banking &amp; Financial Services, Commercial Real Estate, Construction, Health Care Manufacturing &amp; Distribution NFP &amp; Education, Private Client Services, Professional Services, Public Sector, and Technology &amp; Life Sciences. It derives the majority of its revenues from the Financial Services segment and geographically from the United States.
<h3>Breaking Down CBIZ's Financial Performance</h3>
Revenue Growth: CBIZ's remarkable performance in 3 months is evident. As of 31 December, 2024, the company achieved an impressive revenue growth rate of 40.52%. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Industrials sector, the company excelled with a growth rate higher than the average among peers.
Profitability Metrics:
<ul>
<li>
Gross Margin: With a low gross margin of -13.45%, the company exhibits below-average profitability, signaling potential struggles in cost efficiency compared to its industry peers.
</li>
<li>
Earnings per Share (EPS): CBIZ's EPS is below the industry average. The company faced challenges with a current EPS of -1.807303. This suggests a potential decline in earnings.
</li>
</ul>
Debt Management: CBIZ's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 1.03.
Market Valuation:
<ul>
<li>
Price to Earnings (P/E) Ratio: CBIZ's stock is currently priced at a premium level, as reflected in the higher-than-average P/E ratio of 89.95.
</li>
<li>
Price to Sales (P/S) Ratio: With a lower-than-average P/S ratio of 2.04, the stock presents an attractive valuation, potentially signaling a buying opportunity for investors interested in sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): The company's EV/EBITDA ratio 39.87 is above the industry average, suggesting that the market values the company more highly for each unit of EBITDA. This could be attributed to factors such as strong growth prospects or superior operational efficiency.
</li>
</ul>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Exploring the Significance of Insider Trading</h3>
Insider transactions contribute to decision-making but should be supplemented by a comprehensive investment analysis.
When discussing legal matters, the term "insider" refers to any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, as stipulated in Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and significant hedge funds. Such insiders are required to report their transactions through a Form 4 filing, which must be completed within two business days of the transaction.
A new purchase by a company insider is a indication that they anticipate the stock will rise.
On the other hand, insider sells may not necessarily indicate a bearish view and can be motivated by various factors.
<h3>Navigating the World of Insider Transaction Codes</h3>
Surveying the realm of stock transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> often give prominence to those unfolding in the open market, systematically detailed in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C denotes the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000944148">Check Out The Full List Of CBIZ's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

News

Insider Trades

Trading Ideas

CBIZ Board Member Sold $468K In Company Stock

CBIZ (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBZ#NYSE">CBZ</a>) is looking for FY2025 GAAP EPS of $1.97-$2.02 vs $3.02 analyst estimate..

Guidance

CBIZ Sees FY2025 GAAP EPS $1.97-$2.02 vs $3.02 Est

CBIZ (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBZ#NYSE">CBZ</a>) is looking for FY2025 Adj EPS of $3.60-$3.65 vs $3.08 analyst estimate. sees sales of $2.900 billion-$2.950 billion vs $2.21 billion analyst estimate.

CBIZ Sees FY2025 Adj EPS $3.60-$3.65 vs $3.08 Est; Sees Sales $2.900B-$2.950B vs $2.21B Est

CBIZ (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBZ#NYSE">CBZ</a>) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.24) by 16.67 percent. This is a 23.08 percent increase over losses of $(0.26) per share from the same period last year. The company reported quarterly sales of $460.28 million which beat the analyst consensus estimate of $406.60 million by 13.20 percent. This is a 40.52 percent increase over sales of $327.55 million the same period last year.

Earnings

Earnings Beats

CBIZ Q4 Adj EPS $(0.20) Beats $(0.24) Estimate, Sales $460.28M Beat $406.60M Estimate

AAOI

ABEV

ACAD

ACMR

ADTN

ALEC

AMBA

AMBC

AMSF

ARDT

ARHS

ARIS

ARKO

ASTE

ATEC

AVDX

AVNS

BATRA

BATRK

BBSI

BLMN

BXSL

BYND

CAPL

CDNA

CERT

CLDT

CLPT

COCO

COMM

CORT

Core Scientific, Inc. - Class A Common Stock

CORZ

CPRX

CRGY

CSAN

CTRI

DHIL

DMRC

DOLE

DORM

EBAY

ECPG

EHTH

ENIC

ENOV

ERII

ESCA

ESTA

EVTC

FTAI

FWRD

GERN

GOGL

GSX Techedu Inc. American Depositary Shares

GOTU

GRBK

HCAT

HNST

IBTA

IMCR

Earnings Scheduled For February 26, 2025

Management

CBIZ Names Brad Lakhia As Next CFO, Succeeding Ware H. Grove After 24 Years, With Transition Effective March 17, 2025

WIIM

ALIT

CRAI

ELWS

EXPO

HSII

HURN

INOD

KELYA

PAYC

PAYX

PCTY

TNET

Shares of professional service companies are trading higher after Donald Trump won the 2024 presidential election.

CBIZ shares are trading higher following a Q3 EPS beat.

U.S. stocks were higher, with the Dow Jones index gaining around 50 points on Tuesday.
Shares of Corning Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLW#NYSE">GLW</a>) rose sharply during Tuesday's session after reporting better-than-expected third-quarter financial results and issued better-than-expected <a href="https://www.benzinga.com/quote/GLW/earnings">fourth-quarter outlook</a>.
Corning reported quarterly earnings of 54 cents per share which beat the analyst consensus estimate of 52 cents per share. The company reported quarterly sales of $3.73 billion which beat the analyst consensus estimate of $3.72 billion.
Corning shares jumped 7% to $50.12 on Tuesday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>GeneDx Holdings Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WGS#NASDAQ">WGS</a>) shares jumped 39% to $77.96 after the company reported better-than-expected third-quarter financial results and raised its FY24 revenue guidance.</li>
<li>V.F. Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VFC#NYSE">VFC</a>) shares gained 25.3% to $21.35 after the company reported better-than-expected second-quarter financial results.</li>
<li>Canaan Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAN#NASDAQ">CAN</a>) gained 18% to $1.25.</li>
<li>Lithium Americas Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAC#NYSE">LAC</a>) climbed 15.7% to $4.79. Lithium Americas closed $2.26 billion U.S. DOE ATVM loan.</li>
<li>Opera Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPRA#NASDAQ">OPRA</a>) gained 15.5% to $19.48 after the company reported better-than-expected third-quarter financial results and raised its FY24 revenue guidance..</li>
<li>Inari Medical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NARI#NASDAQ">NARI</a>) gained 15.1% to $49.00 after the company reported better-than-expected third-quarter sales results and raised its FY24 revenue guidance above estimates. Also, Piper Sandler maintained a Neutral rating on the stock and raised its price target from $50 to $5.</li>
<li>Shutterstock, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SSTK#NYSE">SSTK</a>) gained 11.7% to $32.98 after the company reported better-than-expected third-quarter financial results and issued FY24 guidance above estimates. Also, the company announced it will integrate its GIPHY API into TikTok&#8217;s messaging platform.</li>
<li>IPG Photonics Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPGP#NASDAQ">IPGP</a>) gained 9.3% to $86.61 following upbeat quarterly earnings.</li>
<li>Rambus Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMBS#NASDAQ">RMBS</a>) gained 8.7% to $48.74 following third-quarter results.</li>
<li>Incyte Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INCY#NASDAQ">INCY</a>) rose 8.4% to $71.21 after the company reported better-than-expected third-quarter revenue results and raised its FY24 net product revenue guidance.</li>
<li>Hayward Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HAYW#NYSE">HAYW</a>) gained 8.3% to $16.03 after the company reported better-than-expected third-quarter financial results and raised the lower end of its FY24 net sales guidance range.</li>
<li>CBIZ, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBZ#NYSE">CBZ</a>) rose 7.5% to $71.88 following upbeat quarterly earnings.</li>
<li>Rubrik, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBRK#NYSE">RBRK</a>) rose 7% to $43.42.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41598309/wall-streets-most-accurate-analysts-give-their-take-on-3-consumer-stocks-delivering-high-dividend-yi">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Consumer Stocks Delivering High-Dividend Yields</a></li>
</ul>

Intraday Update

Markets

Movers

HAYW

INCY

IPGP

NARI

OPRA

RBRK

RMBS

SSTK

Corning Posts Upbeat Q3 Earnings, Joins Opera, Inari Medical, Incyte And Other Big Stocks Moving Higher On Tuesday

CBIZ (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBZ#NYSE">CBZ</a>) affirms FY2024 Adj EPS guidance from $2.64-2.69 to $2.64-2.69 vs $2.64 analyst estimate. Affirms FY2024 sales outlook from $1.70 billion-1.73 billion to $1.70 billion-1.73 billion vs $2.13 billion estimate.

CBIZ Affirms FY2024 Adj EPS Guidance to $2.64-2.69 vs $2.64 Est; Total revenue to grow within a range of 7% to 9% over the prior year.

CBIZ (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBZ#NYSE">CBZ</a>) reported quarterly earnings of $0.84 per share which beat the analyst consensus estimate of $0.76 by 10.53 percent. The company reported quarterly sales of $438.884 million which missed the analyst consensus estimate of $441.695 million by 0.64 percent. This is a 6.90 percent increase over sales of $410.539 million the same period last year.

Earnings Misses

CBIZ Q3 2024 Adj. EPS $0.84 Beats $0.76 Estimate, Sales $438.884M Miss $441.695M Estimate

CBIZ (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBZ#NYSE">CBZ</a>) is set to give its latest quarterly earnings report on Tuesday, 2024-10-29. Here's what investors need to know before the announcement.
Analysts estimate that CBIZ will report an earnings per share (EPS) of $0.76. 
The announcement from CBIZ is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
<h3>Past Earnings Performance</h3>
Last quarter the company missed EPS by $0.18, which was followed by a 5.26% increase in the share price the next day.
Here's a look at CBIZ's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.68</td>
<td>1.50</td>
<td>-0.28</td>
<td>0.59</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.50</td>
<td>1.54</td>
<td>-0.26</td>
<td>0.66</td>
</tr>
<tr>
<td>Price Change %</td>
<td>5.0%</td>
<td>-4.0%</td>
<td>2.0%</td>
<td>-1.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1730127787_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of CBIZ were trading at $66.39 as of October 25. Over the last 52-week period, shares are up 28.0%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<h3>Analyst Observations about CBIZ</h3>
Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on CBIZ.
The consensus rating for CBIZ is Buy, derived from 1 analyst ratings. An average one-year price target of $86.0 implies a potential 29.54% upside.
<h3>Peer Ratings Overview</h3>
The following analysis focuses on the analyst ratings and average 1-year price targets of ICF International, Amentum Holdings and Clarivate, three prominent industry players, providing insights into their relative performance expectations and market positioning.
<ul>
<li>ICF International is maintaining an Outperform status according to analysts, with an average 1-year price target of $174.0, indicating a potential 162.09% upside.</li>
<li>The consensus outlook from analysts is an Buy trajectory for Amentum Holdings, with an average 1-year price target of $31.0, indicating a potential 53.31% downside.</li>
<li>The prevailing sentiment among analysts is an Neutral trajectory for Clarivate, with an average 1-year price target of $6.0, implying a potential 90.96% downside.</li>
</ul>
<h3>Peer Analysis Summary</h3>
In the peer analysis summary, key metrics for ICF International, Amentum Holdings and Clarivate are highlighted, providing an understanding of their respective standings within the industry and offering insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>CBIZ</td>
<td>Buy</td>
<td>5.40%</td>
<td>$53.64M</td>
<td>2.25%</td>
</tr>
<tr>
<td>ICF International</td>
<td>Outperform</td>
<td>2.39%</td>
<td>$182.70M</td>
<td>2.75%</td>
</tr>
<tr>
<td>Amentum Holdings</td>
<td>Buy</td>
<td>-3.07%</td>
<td>$201M</td>
<td>1.84%</td>
</tr>
<tr>
<td>Clarivate</td>
<td>Neutral</td>
<td>-2.77%</td>
<td>$436.70M</td>
<td>-6.27%</td>
</tr>
</tbody>
</table>

Key Takeaway:
CBIZ ranks at the top for Gross Profit and Return on Equity among its peers. It is in the middle for Revenue Growth.
<h3>Unveiling the Story Behind CBIZ</h3>
CBIZ Inc through its subsidiaries provides professional business services. Its business units have been aggregated into three practice groups: Financial Services, Benefits and Insurance Services, and National Practices. The company provides its services to various industries such as Agribusiness, Agribusiness, SAAS, Construction, Health Care, Oil and Gas, Real Estate, Retail, Financial Institutions, and Government among others. It derives the majority of its revenues from the Financial Services segment and geographically from the United States.
<h3>Breaking Down CBIZ's Financial Performance</h3>
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Over the 3 months period, CBIZ showcased positive performance, achieving a revenue growth rate of 5.4% as of 30 June, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Industrials sector.
Net Margin: CBIZ's net margin excels beyond industry benchmarks, reaching 4.71%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): CBIZ's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 2.25%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): CBIZ's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 0.91%, the company may face hurdles in achieving optimal financial returns.
Debt Management: CBIZ's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.69.
<a href="https://www.benzinga.com/quote/CBZ/earnings">To track all earnings releases for CBIZ visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Glimpse of CBIZ's Earnings Potential

Sidoti &amp; Co. analyst Marc Riddick upgrades CBIZ (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBZ#NYSE">CBZ</a>) from Neutral to Buy and announces $86 price target.

Upgrades

Price Target

Analyst Ratings

Sidoti & Co. Upgrades CBIZ to Buy, Announces $86 Price Target

CBIZ shares are trading lower after the company reported worse-than-expected Q2 financial results. Additionally, the company announced it entered into an agreement to acquire the Non-attest business of Marcum in a cash and stock transaction value at $2.3 billion.

CBIZ (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBZ#NYSE">CBZ</a>) reported quarterly earnings of $0.50 per share which missed the analyst consensus estimate of $0.68 by 26.47 percent. This is a 9.09 percent decrease over earnings of $0.55 per share from the same period last year. The company reported quarterly sales of $420.01 million which missed the analyst consensus estimate of $430.38 million by 2.41 percent. This is a 5.40 percent increase over sales of $398.50 million the same period last year.

CBIZ Q2 Adj. EPS $0.50 Misses $0.68 Estimate, Sales $420.01M Miss $430.38M Estimate

CBIZ Entered Into A Definitive Agreement To Acquire The Non-attest Business Of Marcum In A Cash-and-stock Transaction Is Valued At Approximately $2.3B

CBIZ Sees FY24 Revenue Growth Of 7% - 9%; Adj EPS Of $2.70 - $2.75 Vs. $2.72 Est.

CBIZ (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBZ#NYSE">CBZ</a>) reported quarterly earnings of $1.54 per share which beat the analyst consensus estimate of $1.50 by 2.67 percent. This is a 5.48 percent increase over earnings of $1.46 per share from the same period last year. The company reported quarterly sales of $494.30 million which beat the analyst consensus estimate of $490.88 million by 0.70 percent. This is a 8.73 percent increase over sales of $454.61 million the same period last year.

CBIZ Q1 Adj $1.54 Beats $1.50 Estimate, Sales $494.30M Beat $490.88M Estimate

CBIZ, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBZ#NYSE">CBZ</a>) ("the Company"), a leading provider of financial, insurance and advisory services, announced today it has acquired technology solutions provider, CompuData, Inc. (CompuData), of Philadelphia, PA, effective March 1, 2024.
Founded in 1971, CompuData is a premier technology solutions provider for small and midsize organizations. They provide cloud computing, accounting ERP software, managed IT and security to clients with the tools to scale, protect, and streamline their organizations. CompuData is a Sage Diamond Partner and has Microsoft Partner designation in both Azure Cloud and Modern Work. The firm has 60 employees and approximately $20 million in annual revenue.
Jerry Grisko, President and CEO of CBIZ, said, "We have experienced an increasingly high demand across the country for precisely the suite of services that CompuData has built an impressive reputation providing. In the CompuData team, we have found a partner that is equally invested in and dedicated to its clients' success by offering essential solutions that they rely on. For these reasons and more, we are thrilled to welcome CompuData to CBIZ."
Angela Nadeau, President and CEO of CompuData, stated, "Our entire team is very excited to join forces with such a strong and nationally recognized partner such as CBIZ. Our industry verticals, including financial services, construction, manufacturing, distribution, and technology, align extremely well. We see great opportunity and expect our partnership to be mutually beneficial to our valued employees and clients."

CBIZ Acquires Compudata, Inc.; Financial Terms Of Transaction Not Disclosed

CBIZ (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBZ#NYSE">CBZ</a>) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.27) by 3.7 percent. The company reported quarterly sales of $327.55 million which beat the analyst consensus estimate of $309.02 million by 5.99 percent. This is a 11.02 percent increase over sales of $295.04 million the same period last year.

CBIZ Q4 2023 Adj EPS $(0.26) Beats $(0.27) Estimate, Sales $327.55M Beat $309.02M Estimate

Press Releases

October's Small Business Hiring Data Continues to Show Weakness

CBIZ APPOINTS BRAD LAKHIA AS NEXT CHIEF FINANCIAL OFFICER

Small Business Hiring Continues to Trend Downward in November

Infrastructure and Manufacturing Megaprojects Propel Construction Industry in Q3 2024

Middle-Market CEOs Sound Alarm on Tariff Impacts and Tax Policy Uncertainty

CBIZ Board Adds Kathy Raffa as Independent Director

CBIZ Appoints Six National Industry Leaders to Ensure Delivery of Tailored Expertise to Clients

Comments

CBIZ

ニュース

パートナーシップ

ベンジンガ・グローバル